MOSCOW (MRC) -- Alpek, the petrochemicals arm of Mexican conglomerate Alfa (BMV: ALFA), reported a profit attributable to controlling interests of USD61mn in the first quarter, down 22% year-on-year as a result of a 23% decrease in operating income, to USD119mn, said Bnamericas.
Compared to the fourth quarter, profit increased 100% due to improving export markets outside North America after the fourth quarter and a decrease in financing expenses due to the company's 2012 debt refinancing, Alpek said in a statement.
Ebitda declined 18% to USD160mn in the first quarter from USD196mn a year earlier. Compared to 4Q12, Ebitda rose 14%.
Sales in the quarter were down 4% year-on-year but up 9% sequentially to USD1.83bn.
Capex for the quarter was USD66mn, increasing 370% year-on-year driven by the ongoing investment in the Cosoleacaque cogeneration plant and the first payment related to the IntegRex PTA license agreement and a PTA-PET sourcing agreement with Italian chemicals group M&G.
Net debt at end March amounted to USD747mn, down 38% or USD461mn from a year ago, while gross debt declined by 21% over the period.
Alfa also owns Nemak (aluminum auto components), Sigma (refrigerated foods) and Alestra (telecommunications).
As MRC wrote earlier, M&G Group signed a Licensee Agreement with Alpek, S.A.B. de C.V. (Alpek) for IntegRex PTA technology. The technology will be used in the construction of M&G's previously announced 1,200,000 MT per annum PTA plant at Corpus Christi, Texas. M&G also announces today, Alpek has purchased for a price of USD350,000,000, a multiyear sourcing agreement covering rights to 400,000 MT of PET (made with 336,000 MT of integrated PTA) per year.
Alpek is the largest petrochemical company in Mexico and the second largest in Latin America. The company operates through two business segments: Polyester chain products (PTA, PET and polyester fibers), and Plastics and Chemicals products (PP, EPS, caprolactam, polyurethanes and other specialty and industrial chemicals). Alpek is a leading producer of PTA and PET worldwide, operates the largest expandable polystyrene plant in America and one of the largest polypropylene plants in North America. It is also the only producer of caprolactam in Mexico. In 2012, Alpek reported revenues of USD7,277 million and EBITDA of U.S. USD728 million. The company operates 20 plants in Mexico, USA and Argentina, and employs 4,700 people. Alpek is a publicly traded company listed on the Mexican Stock Exchange.
MRC